The Mammalian Target of Rapamycin Signaling Pathway Mediates Epileptogenesis in a Model of Temporal Lobe Epilepsy

Por Zeng, Ling-Hui, Rensing, Nicholas R., Wong, Michael
Publicado em 2009

Developing Antiepileptogenic Drugs for Acquired Epilepsy: Targeting the Mammalian Target of Rapamycin (mTOR) Pathway

Por Zeng, Ling-Hui, Rensing, Nicholas R., Wong, Michael
Publicado em 2009

Brief Seizures Cause Dendritic Injury

Por Guo, Dongjun, Arnspiger, Sarah, Rensing, Nicholas R., Wong, Michael
Publicado em 2011

Vigabatrin Inhibits Seizures and mTOR Pathway Activation in a Mouse Model of Tuberous Sclerosis Complex

Por Zhang, Bo, McDaniel, Sharon S., Rensing, Nicholas R., Wong, Michael
Publicado em 2013

Regulation of Cell Death and Epileptogenesis by the Mammalian Target of Rapamycin (mTOR): A Double-Edged Sword?

Por Zeng, Ling-Hui, McDaniel, Sharon, Rensing, Nicholas R, Wong, Michael
Publicado em 2010

Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex

Por Zhang, Bo, Zou, Jia, Rensing, Nicholas R, Yang, Meihua, Wong, Michael
Publicado no Neurobiol Dis (2015)

The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway

Por McDaniel, Sharon S., Rensing, Nicholas R., Thio, Liu Lin, Yamada, Kelvin A., Wong, Michael
Publicado em 2011

Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of Tuberous Sclerosis Complex

Por Zeng, Ling-Hui, Rensing, Nicholas R., Zhang, Bo, Gutmann, David H., Gambello, Michael J., Wong, Michael
Publicado em 2011

Kainate Seizures Cause Acute Dendritic Injury and Actin Depolymerization In Vivo

Por Zeng, Ling-Hui, Xu, Lin, Rensing, Nicholas R., Sinatra, Philip M., Rothman, Steven M., Wong, Michael
Publicado em 2007